|
Percutaneous closure of patent foramen ovale for stroke prevention |
Rey-Ares L, Ciapponi A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A, López A |
|
|
Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Rey-Ares L, Ciapponi A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A, López A. Percutaneous closure of patent foramen ovale for stroke prevention. Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS). Informe de Respuesta Rapida No. 500. 2016 Authors' conclusions There is evidence of moderate quality showing that percutaneous closure of a patent foramen ovale for secondary prevention of stroke would be similar or slightly better than medical treatment. The Clinical Practice Guidelines do not recommend it as first option; its indication is limited to patients who failed medical treatment or with contraindications. The United States private sponsors differ in coverage, while the British Public Health System does cover it.
No evidence was found regarding primary prevention of stroke and the only guide mentioning primary prevention recommends.
Final publication URL www.iecs.org.ar Indexing Status Subject indexing assigned by CRD MeSH Foramen Ovale, Patent; Humans; Stroke Language Published Spanish Country of organisation Argentina English summary An English language summary is available. Address for correspondence Institute for Clinical Effectiveness and Health Policy, Viamonte 2146 - 3 Piso, C1056ABH Ciudad de Buenos Aires, Argentina Tel: +54 11 49 66 00 82 Fax:+54 11 49 53 40 58 Email: info@iecs.org.ar AccessionNumber 32016001120 Date abstract record published 25/11/2016 |
|
|
|